Awards

BEST ORAL COMMUNICATIONS

C0126
Value-based pricing for dabigatran, rivaroxaban and apixaban in patients
with non-valvular atrial fibrillation in Germany
Martin Krejczy, Svetlana Marx, Konrad Obermann, Martin Wehling, Job Harenberg
Faculty of medicine Mannheim, Ruprecht-Karls University Heidelberg. Germany

C0081
Tissue factor expression and microRNAs –17-5p and –20a in endometrial cell
cultures from women with endometriosis: its modulation by peritoneal fluid
Aitana Braza-Boils, Juan Gilabert-Estellés, Luis Andrés Ramón, Juan Gilabert Aguilar, Melitina Chirivella Casanova, Francisco España Furió, Amparo Estellés Cortés
Hospital Universitario La Fe, Valencia. Spain

C0016
INTERNATIONAL GOOD CLINICAL PRACTICES (GCP) GUIDELINES FOR ANTITHROMBOTICS IN CANCER PATIENTS
Dominique Farge-Bancel, P. Debourdeau
Groupe Francophone Thrombose et Cancer, Assistance Publique Hôpitaux de Paris, Saint-Louis Hospital

BEST POSTERS

P0084
The effect of CME educational programs on VTE morality & morbidity in King
Fahad Hospital – Jeddah –KSAEssam AboElNazar, Fahd Alhameed
UMQ University, Yeddah, Saudi Arabia

P0336
Venous thromboembolism (VTE) at rare sites in neonates and children
Pergantou Helen, Avgeri Maria, Komitopoulou Anna, Xafaki Panagiota, Kapsimali Zoey, Karelioti Helen, Platokouki Helen Aghia Sophia Children’s hospital , Athens. Greece

P0110
SERUM LEVELS OF VITAMIN D IS NOT ASSOCIATED WITH FUTURE RISK OF VENOUS
THROMBOEMBOLISM – THE TROMSØ STUDY
Ellen Brodin, Gunhild Lerstad, Guri Grimnes, Sigrid Brækkan, Johan Svartberg, Rolf Jorde, John-Bjarne Hansen
Hematological Research group (HERG) University of Tromso. Norway

P0392
Cancer-associated thrombosis; a study of 806 cases of deep venous thrombosis Smiti Khanfir Monia, Bellakhal Syrine, Hamzaoui Amira, Ben Salem Thouraya
Braham-Sfaxi Amel, Ben Ghorbel Imed, Lamloum Mounir, Houman Mohamed-Habib
La Rabta Univrsity Hospital, Tunis

---

The Mediterranean League Against Thromboembolic Diseases (M LTD) will provide awards, to medical trainees and young scientists (under 35 years of age) who submit highly rated communications, which will be presented on the 22nd International Congress on Thrombosis.

1. CANDIDATES

The Young Investigator must be the presenter and first author of an abstract submitted to the Congress. To receive the award, a recipient must be present at the Congress, and a current passport showing date of birth is required to collect the award on site at MLTD 2012. Please check the relevant box on the abstract submission form to apply for this award.

2. REWARD

The MLTD will provide 8 awards: 4 for the best oral presentations (1.000 €) and 4 for the best poster presentations (500€)

3. JURY AND AWARD CEREMONY

The Scientific Committee of the Congress will be responsible for assessing the best oral communications and the best posters. This assessment will take place during the 22nd International Congress on Thrombosis.
The award ceremony will take place during the gala dinner of the congress.